BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22366649)

  • 1. Amyloid precursor protein accumulates in aggresomes in response to proteasome inhibitor.
    Dehvari N; Mahmud T; Persson J; Bengtsson T; Graff C; Winblad B; Rönnbäck A; Behbahani H
    Neurochem Int; 2012 Apr; 60(5):533-42. PubMed ID: 22366649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-proteasome pathway mediates degradation of APH-1.
    He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
    J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of BACE by the ubiquitin-proteasome pathway.
    Qing H; Zhou W; Christensen MA; Sun X; Tong Y; Song W
    FASEB J; 2004 Oct; 18(13):1571-3. PubMed ID: 15289451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.
    Flood F; Murphy S; Cowburn RF; Lannfelt L; Walker B; Johnston JA
    Biochem J; 2005 Jan; 385(Pt 2):545-50. PubMed ID: 15473868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
    Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
    J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
    Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
    J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc73.
    Kouchi Z; Sorimachi H; Suzuki K; Ishiura S
    Biochem Biophys Res Commun; 1999 Jan; 254(3):804-10. PubMed ID: 9920821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo.
    Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS
    J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an experimental proteasome inhibitor on the cytoskeleton, cytosolic protein turnover, and induction in the neuronal cells in vitro.
    Csizmadia V; Raczynski A; Csizmadia E; Fedyk ER; Rottman J; Alden CL
    Neurotoxicology; 2008 Mar; 29(2):232-43. PubMed ID: 18155769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
    Kumar-Singh S; Dewachter I; Moechars D; Lübke U; De Jonghe C; Ceuterick C; Checler F; Naidu A; Cordell B; Cras P; Van Broeckhoven C; Van Leuven F
    Neurobiol Dis; 2000 Feb; 7(1):9-22. PubMed ID: 10671319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Proteasome inhibitors induce nuclear ribonucleoprotein inclusions that accumulate several key factors of neurodegenerative diseases and cancer.
    Latonen L
    Bioessays; 2011 May; 33(5):386-95. PubMed ID: 21425306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
    Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
    Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
    J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells.
    Peng Y; Jiang L; Lee DY; Schachter SC; Ma Z; Lemere CA
    J Neurosci Res; 2006 Sep; 84(4):903-11. PubMed ID: 16862548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.